Skip to content
Institutional Investor Series A Series B Series C Series E growth Est. 2018

Skyviews Life Science

Provider of advisory services focused on precision health and longevity investments

📍 Grandvaux, France

About This Fund

Provider of advisory services focused on precision health and longevity investments. The company identifies opportunities in biotechnology, advanced nutrition, and digital health. It targets companies with drugs, technology platforms, preventive strategies, personalized solutions, and natural foods. The company leverages partners from academic, corporate, consumer, and venture capital sectors. Its perspective is rooted in predictive, preventive, personalized, and participatory medicine.

Investment Focus

Sectors
biotechnology advanced nutrition digital health precision health longevity
Stages
Series A Series B Series C Series E growth
Check Size $1M-$10M (participates in $20M-$100M rounds)
Geography
Global USA Israel Europe

What They Look For

Global companies (US, Europe, Israel) developing better drugs, advanced tech platforms, preventive/personalized health solutions, natural foods; no specific revenue/team thresholds

Preparing to pitch Skyviews Life Science?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →